n. ritalin ; methylphenidate
(1)哌甲酯(methylphenidate)：主要应用于6岁以上小儿，每日0.2～0.5mg/kg，个别可达每日0.7～1.0mg/kg，最大量一般每日不超过40mg。
基于5510个网页-相关网页
... 甲戊炔醇 Methylparafynol；Methylpentynol 哌甲酯 Methylphenidate；Methylphenidylacetate 醋丙甲泼尼龙 Methylprednisolone ...
基于82个网页-相关网页
...哌甲酯(meth-ylphenidate,MPH)是美国儿科学会建议用于ADHD治疗的中枢神经 系统兴奋剂之一。国外研究示ADHD患儿对兴奋剂的依从性为35~100[2]。
基于2个网页-相关网页
盐酸哌甲酯控释片 Methylphenidate Hydrochloride Controlled-Release Tablets ; Methylphenidate Hydrochloride Extended-release Tablets ; Methylphenidate ; Methylphenidate Hydrochloride
盐酸哌甲酯 Methylphenidate Hydrochloride ; methylphenidate HCl ; RITALINIC ACID ; Methyl 2-phenyl-2-acetate hydrochloride
盐酸哌甲酯缓释片 Methylphenidate HCl Extended-release Tablets ; Methylphenidate HCl Extended-rel ; Methylphenidat
盐酸哌甲酯片 Methylphenidate Hydrochloride Tablets
哌甲酯控释片 Methylphenidate Hydrochloride Controlled-Release Tablets
注射用盐酸哌甲酯 Methylphenidate Hydrochloride for Injection
哌甲酯缓释片 Methylphenidate HCl Extended-release Tablets
盐酸右哌甲酯 DEXMETHYLPHENIDATE HYDROCHLORIDE
盐酸哌甲酯口服液 METHYLIN ORAL SOLUTION
Objective Methylphenidate is recommended as a first-line modality for treating attention deficit hyperactivity disorder(ADHD).
目的盐酸哌甲酯是目前治疗注意缺陷多动障碍(ADHD)的首选药物。
参考来源 - 盐酸哌甲酯控释片治疗注意缺陷多动障碍疗效观察·2,447,543篇论文数据，部分数据来源于NoteExpress
方法：以水为溶媒用一阶导数光谱法测定盐酸哌甲酯片的含量及含量均匀度。
Methods: the first derivation spectrophotometry method was used to determine the content and content uniformity of methylphenidate hydrochloride tablets with the solvent of water.
两组均接受药物哌甲酯的治疗，实验组同时引入感觉统合训练，疗程10周。
Patients in both groups received drug therapy of methylphenidate, besides sensory integration training was given to those in the study group, and the course was 10 weeks.
结论：药物浓度、不同促透剂及其浓度对盐酸哌甲酯的经皮渗透有一定的影响。
Conclusion: Transdermal absorption of MPH can be affected by the concentration of drug and various penetration enhancers.
应用推荐